 SAN DIEGO, March 17, 2021 PRNewswire -- Evofem Biosciences, Inc., NASDAQ: EVFM today announced that Get Phexxi, its national direct-to-consumer DTC campaign aimed at broadening awareness of its non-hormonal, on-demand birth control method, Phexxi lactic acid, citric acid and potassium bitartrate vaginal gel, achieved significant initial results. We believe the initial results from our Get Phexxi marketing campaign demonstrate that we are achieving our goals for this campaign: to raise awareness of this important birth control option and to drive women to healthcare practices for Phexxi, said Evofem Biosciences CEO, Saundra Pelletier. 